Clinical Trial Update: A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase II trial of ZIO 101 for advanced hepatocellular carcinoma, sponsored by Alaunos Therapeutics, with no status details…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ZIO-101

Snippet

Sponsor: Alaunos Therapeutics | Conditions: HEPATOCELLULAR CARCINOMA | Phase 2 | Status: UNKNOWN